ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
11 announcements with these filters
Sonitron Limited, a promoter group entity, acquired 10,000 equity shares of Dhampur Bio Organics Limited through the open market. This acquisition increased the promoter's stake by 0.015%.
Promoter Group entity Sonitron Limited acquired 10,000 shares of Dhampur Bio Organics Ltd via market purchase for Rs.0.11 Crore, increasing their stake to 17.37%.
DBO Employee Welfare Trust bought 10,000 Dhampur Bio Organics shares on NSE for ₹0.11 Crore. Routine ESOP trust inventory purchase.
DBO Employee Welfare Trust acquired 20,000 equity shares of Dhampur Bio Organics Ltd via market purchase on September 17 and 18, 2026.
DBO Employee Welfare Trust purchased 25,000 equity shares via market route on September 15-16, 2026. The total consideration for these acquisitions is ₹0.29 Crore.
DBO Employee Welfare Trust acquired 5,000 equity shares of Dhampur Bio Organics Ltd via market purchase for Rs. 0.06 Crore.
DBO Employee Welfare Trust purchased 5,000 equity shares of Dhampur Bio Organics Ltd from the market for ₹0.07 Crore on September 3, 2026.
CARE Ratings has reaffirmed the credit rating for Dhampur Bio Organics Limited's bank facilities, assigning CARE BBB+ (Positive) for long-term and CARE A2 for short-term facilities.
Dhampur Bio Organics reported Q1FY27 Revenue of ₹553.88 Cr (up 4.51% YoY) but a loss from continued operations of ₹12.14 Cr. Strategic focus is transitioning to value-added sugar, spirits, and bio-energy.
Dhampur Bio Organics reported FY26 revenue of ₹2,082.01 Cr (up 10.57% YoY) and EBITDA of ₹162.01 Cr. Strategy focuses on value-added sugar and bio-energy transition.
Dhampur Bio Organics Ltd reported revenue from operations of ₹773.6 Cr (+10.1% YoY) and net profit of ₹46.3 Cr (+3.3% YoY) for Q4 FY26.